Status:
ENROLLING_BY_INVITATION
Enhancing Calm in Arab Elderly With Dementia
Lead Sponsor:
Mostafa Shaban
Conditions:
Dementia
Agitation in Dementia, Including Alzheimer's Disease
Eligibility:
All Genders
60-90 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness of integrating Snoezelen methods with aromatherapy and personal items in reducing agitation in Arab elderly individuals with dementia. ...
Detailed Description
This clinical trial is centered on a novel approach to dementia care, specifically targeting the Arab elderly demographic. It uniquely combines three elements - Snoezelen therapy, aromatherapy, and th...
Eligibility Criteria
Inclusion
- For the study \"Enhancing Calm in Arab Elderly with Dementia: Integrating Snoezelen Methods with Aromatherapy and Personal Items to Reduce Agitation\", here are the suggested Inclusion and
Exclusion
- Inclusion Criteria:
- Age: Participants must be 65 years to 90 years
- Diagnosis: Clinical diagnosis of dementia required.
- Ethnicity: Must be of Arab descent.
- Agitation Levels: Must show agitation signs based on a standardized scale.
- Cognitive Function: Adequate cognitive function for study participation, verified by standard assessment.
Key Trial Info
Start Date :
January 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06216275
Start Date
January 5 2024
End Date
March 1 2024
Last Update
February 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo university
Giza, Egypt